Immunovant, Inc.
NASDAQ:IMVT
15.34 (USD) • At close June 4, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 713.971 | 635.365 | 376.532 | 493.817 | 400.146 | 100.571 | 0.325 | 0 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 713.971 | 635.365 | 376.532 | 493.817 | 400.146 | 100.571 | 0.325 | 0 |
| Net Receivables
| 2.084 | 5.503 | 0.885 | 12.861 | 1.144 | 3.045 | 0 | 0 |
| Inventory
| 0 | 0 | -0 | -0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 51.607 | 24.902 | 26.916 | 6.253 | 7.716 | 5.46 | 0 | 0.113 |
| Total Current Assets
| 767.662 | 665.77 | 404.333 | 512.931 | 409.006 | 109.076 | 0.325 | 0.113 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 0.942 | 0.595 | 1.505 | 2.633 | 3.483 | 0.065 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 7.618 | 0 | 0 | 0 | 0 | 0.246 | 0.08 | 0 |
| Total Non-Current Assets
| 8.56 | 0.595 | 1.505 | 2.633 | 3.483 | 0.311 | 0.08 | 0 |
| Total Assets
| 776.222 | 666.365 | 405.838 | 515.564 | 412.489 | 109.387 | 0.405 | 0.113 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 17.656 | 7.155 | 1.353 | 18.629 | 2.432 | 1.19 | 0 | 1.136 |
| Short Term Debt
| 0.098 | 0.138 | 1.173 | 1.145 | 2.358 | 3.19 | 0.3 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | -3.19 | -0 | 0 |
| Other Current Liabilities
| 33.365 | 41.315 | 40.771 | 24.746 | 13.981 | 10.938 | 0.08 | 0.474 |
| Total Current Liabilities
| 68.775 | 48.608 | 43.297 | 44.52 | 18.771 | 15.318 | 0.38 | 1.61 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 0 | 0 | 0.047 | 1.219 | 2.238 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0.347 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | -0.347 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 0 | 0.347 | 0.047 | 1.219 | 2.238 | 14.128 | 0.3 | 0 |
| Total Liabilities
| 68.775 | 48.608 | 43.344 | 45.739 | 21.009 | 15.318 | 0.38 | 1.61 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 0.016 | 0.014 | 0.013 | 0.012 | 0.01 | 0.005 | 0 | 0 |
| Retained Earnings
| -1,239.523 | -825.683 | -566.347 | -355.387 | -198.657 | -91.226 | -0 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 1.459 | 1.908 | 0.852 | 0.404 | -0.298 | -0.016 | 0.343 | -1.497 |
| Other Total Stockholders Equity
| 1,945.495 | 1,441.518 | 927.976 | 824.796 | 590.425 | 185.306 | 0.025 | 0 |
| Total Shareholders Equity
| 707.447 | 617.757 | 362.494 | 469.825 | 391.48 | 94.069 | 0.025 | -1.497 |
| Total Equity
| 707.447 | 617.757 | 362.494 | 469.825 | 391.48 | 94.069 | 0.025 | -1.497 |
| Total Liabilities & Shareholders Equity
| 776.222 | 666.365 | 405.838 | 515.564 | 412.489 | 109.387 | 0.405 | 0.113 |